(Q53165773)

English

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Daniela Boggiani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Michele Panebianco

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Giovanna Vasini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Stefania Salvagni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Vittorio Franciosi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Andrea Ardizzoni

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

0 references

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

964-973

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20960528%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: a multicenter experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Non-Hodgkin's malignant lymphomas in patients older than 80. 70 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

21 January 2018

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25582

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53165773&oldid=1773233131"